پديد آورندگان :
Montaseri Hashem نويسنده , Jamei Forough نويسنده , Khairollahi Koulsoum نويسنده , Cheraghali A. Majid نويسنده
چكيده لاتين :
In order to ensure the safety of parenterals, international pharmacopoeias and
national standards have set up stringent guidelines and standards. Particulate
contamination is a potential health risk caused by intravenous injection of particles
large enough to potentially clog the small arteries. Particles could be produced through
manufacturing and packaging or even dispensing of the pharmaceuticals. The
nature of the particles are varied and could be of drug itself, packaging debris, rubber,
plastic, cotton, fiber and glass particles, which might be produced during the
breakage of an ampoule. In this study, some of the small volume parenterals
available in Iranian drug market have been investigated for the presence of particles.
Although, most of the tested samples passed national standard tests for particulate
contamination of small volume parenterals, 40% of the samples were rejected
using the same protocols. Therefore, it appears that particulate contamination of
parenterals creates an additional source of risk for patients who receive these
medications, intravenously.